Home| About Us| Contact Us| Policies| How To Buy| Sign In
 

Comparisons

Comparison with other electromedical modalities

In contrast to other electromedical treatments of psychological and psychiatric disorders, CES utilizes very mild, low-frequency currents often below sensory thresholds in most patients. Unlike Deep Brain Stimulation (DBS) or Vagus Nerve Stimulation (VNS), CES does not require surgical implantation of electrodes and is therefore substantially less expensive and safer. A very low incidence of side effects (usually mild and self-limiting) and a high clinical efficacymake CES an attractive modality that should be considered a first-line medical treatment for anxiety, stress or insomnia in many patients.

Modality

Primary indications

Mechanism (parameters)

U.S. regulatory status

CES

(Cranial Electrotherapy Stimulation)

Anxiety, stress, insomnia

Induction of an alpha state and modulation of electrocortical activity with mild electrical currents to relieve symptoms (9V, < 1mA, 0.5 or 100Hz).

Clinical use

TMS
(Transcranial Magnetic Stimulation)

Severe stress, mania, PTSD, OCD, chronic pain

Modulation of electrocortical activity with electrical currents in the brain generated with a strong external magnetic field.

Investigational

VNS
(Vagus Nerve Stimulation)

Epilepsy, refractory stress

Stimulation with a surgically implanted electrical device to relieve symptoms.

Clinical use

DBS
(Deep Brain Stimulation)

Parkinson's disease, essential tremor, dystonia

Stimulation with a surgically implanted electrical device to relieve symptoms.

Clinical use

ECT
(Electroconvulsive therapy)

Severe stress, mania, schizophrenia

Induction of a bilateral tonic-clonic seizure under anesthesia to relieve symptoms (120-225V, 500-800mA, 30-70Hz).

Clinical use

 

Alpha-Stim is Proven More Efficacious

With 55 completed studies, and many more underway, there is more research supporting Alpha-Stim technology than there is for most drugs. The US government has recently funded two more major Alpha-Stim studies: one is a NCI/NIH study for breast cancer and the other is a VA study for veterans with spinal cord injuries.

Cost-Effective

Alpha-Stim over the medium term has also proven to be more cost-effective. While a high initial cost, ongoing costs are minimal per treatment. See charts below - (Costs in US$).

Use always as directed, always read the label. If symptoms persist contact a health care professional

ARTG No. 137247

 

eXTReMe Tracker
Website by AboutIT
© 2008 - Medistim New Zealand
P.O.Box 34778 Birkenhead, Auckland
Ph: +64 9 4808339